Open Access

Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat

  • Lisa VanHoose1,
  • Youssef Sawers2,
  • Rajprasad Loganathan1,
  • James L Vacek2,
  • Lisa Stehno-Bittel1,
  • Lesya Novikova1,
  • Muhammed Al-Jarrah3 and
  • Irina V Smirnova1Email author
Cardiovascular Diabetology20109:56

https://doi.org/10.1186/1475-2840-9-56

Received: 5 August 2010

Accepted: 22 September 2010

Published: 22 September 2010

Abstract

Background

Early markers of diabetic autonomic neuropathy (DAN) in an electrocardiogram (ECG) include elevated R wave amplitudes, widening of QTc intervals and decreased heart rate variability (HRV). The severity of DAN has a direct relationship with mortality risk. Aerobic exercise training is a common recommendation for the delay and possible reversal of cardiac dysfunction. Limited research exists on ECG measures for the evaluation of aerobic exercise training in Zucker Diabetic Fatty (ZDF) rat, a model of type 2 diabetes. The objective of this study was to assess whether aerobic exercise training may attenuate diabetes induced ECG changes.

Methods

Male ZDF (obese fa/fa) and control Zucker (lean fa/+) rats were assigned to 4 groups: sedentary control (SC), sedentary diabetic (SD), exercised control (EC) and exercised diabetic (ED). The exercised groups began 7 weeks of treadmill training after the development of diabetes in the ED group. Baseline (prior to the training) and termination measurements included body weight, heart weight, blood glucose and glycated hemoglobin levels and ECG parameters. One way repeated measures ANOVA (group) analyzed within and between subject differences and interactions. Pearson coefficients and descriptive statistics described variable relationships and animal characteristics.

Results

Diabetes caused crucial changes in R wave amplitudes (p < 0.001), heart rate variability (p < 0.01), QT intervals (p < 0.001) and QTc intervals (p < 0.001). R wave amplitude augmentation in SD rats from baseline to termination was ameliorated by exercise, resulting in R wave amplitude changes in ED animals similar to control rats. Aerobic exercise training neither attenuated QT or QTc interval prolongation nor restored decreases in HRV in diabetic rats.

Conclusion

This study revealed alterations in R wave amplitudes, HRV, QT and QTc intervals in ZDF rats. Of these changes, aerobic exercise training was able to correct R wave amplitude changes. In addition, exercise has beneficial effect in this diabetic rat model in regards to ECG correlates of left ventricular mass.

Background

Cardiovascular disease (CVD) accounts for the majority of deaths for people with type 2 diabetes mellitus. CVD is a broad term which includes any condition causing pathological changes in blood vessels, cardiac muscle or valves and cardiac rhythm. The electrocardiogram (ECG) offers a quick, non-invasive clinical and research screen for the early detection of CVD.

Electrocardiographic changes in raw and corrected QT intervals and R wave amplitudes are early indicators of evolving CVD and increased cardiovascular risk. Prolonged QT and QTc intervals are considered reliable predictors of heart disease and fatal ventricular arrhythmias [13]. A positive linear relationship exists between QTc interval prolongation and diabetic cardiac autonomic neuropathy (DAN) severity in diabetic population [4]. Heart rate variability (HRV), one indicator of DAN, decreases with diabetes which indicates increased mortality risk [5]. QT and QTc interval abnormalities reflect changes in cardiac architecture. A positive correlation between QT or QTc interval prolongation and left ventricular (LV) mass has been reported [68]. LV hypertrophy presents as exaggerated R wave amplitudes on ECG recordings. Elevated R wave amplitudes are an independent risk factor for cardiovascular events [9]. LV hypertrophy and QT interval alterations coupled with decreased cardiac function are commonly observed with diabetes related CVD [10].

Non pharmacological interventions for CVD focus primarily on lifestyle changes with physical activity as the primary focus and a risk reduction strategy. Physical activity reduces QTc interval prolongation and cardiac dysfunction in healthy subjects [11, 12]. Exercise lowers heart rate and increases HRV in healthy and diseased populations [13, 14]. Physical activity can serve as potent prescription in the delay and attenuation of the CVD complications for persons with type 2 diabetes but additional comparative studies are needed regarding the cardiac response to exercise under diabetic conditions at various time points of the disease.

The Zucker Diabetic Fatty (ZDF) rat is a model of type 2 diabetes. The ZDF rat develops hyperglycemia and hyperlipidemia by week 8 and overt diabetes by week 12. The progression mimics the obesity-related insulin resistance and inflammation seen in humans [15, 16]. The ZDF rat is commonly used to investigate prevention of diabetes; however, research related to the diabetic heart disease including ECG studies with this animal model is limited. We hypothesized that ECG changes occur in ZDF rats early in the disease process and aerobic exercise training is able to alleviate the changes. We detected changes in ECG parameters that were partially corrected by exercise training. Our findings add to the characterization of the ZDF model for studying type 2 diabetes effects on the heart and explore the benefits of an early exercise intervention in the presentation and progression of diabetes related CVD.

Methods

Animals

Male Zucker Diabetic Fatty (fa/fa) rats of 11 weeks were utilized for the study. Male lean, age-matched Zucker (fa/+) rats (both from Charles River Laboratory, Saint Louis, MO) served as non-diabetic controls. The animals were allowed food and water ad libitum and were placed on a 12:12 light-dark cycle. As per vendor's recommendations, the animals were fed Purina 5008 diet during the entire study for the development of a disease process resembling type 2 diabetes and its complications. All animal procedures were performed according to the University of Kansas Medical Center Institutional Animal Care and Use Committee guidelines and an approved Animal Care and Use Protocol.

Measurements

Body weights and blood glucose levels were measured weekly on all animals. Blood glucose levels were measured from rat tail using Accu-Check Active meter (Roche Diagnostics, Indianapolis, IN). Glycated hemoglobin (HbA1c) levels were measured at the end of the experiment using antibody-based A1cNow meter (Metrika, Sunnyvale, CA). When rats had blood glucose or HbA1c levels higher than detectable by the method used, we used the highest detectable value (600 mmol/L or 13%, respectively) for statistical purposes. Animals were killed within 36 hours of the last exercise training episode.

Aerobic exercise training

The rats started a treadmill exercise program at 12 weeks of age, immediately after the onset of diabetes, and continued exercising for 7 weeks. Four groups of rats were used: sedentary control (SC, n = 12), sedentary diabetic (SD, n = 10), exercised control (EC, n = 10) and exercised diabetic (ED, n = 12). This training protocol has been published by our group previously for a rat model of type 1 diabetes [17] and was adapted for the obese diabetic rats as they were unable to perform at that intensity level. During the first week of training the animals ran at 10 m/min with time increased from 10 min per day to 40 min per day at the end of the week. The progression allowed the rats to acclimate to the treadmill. Starting at week two and until the completion of the training session the rats ran at 15 m/min, for 40 minutes, 5 days per week. In order to accommodate for the disease progression in the diabetic rats, any animals showing signs of fatigue were allowed breaks of a few minutes until they were able to continue, for a total run time of 40 min per day. All rats assigned to the exercise groups completed the exercise training protocol.

Electrocardiogram (ECG) assessment

Animals received ketamine (60 mg/kg) and xylazine (7 mg/kg) prior to the resting ECG recording. ECG leads I, II, III, aVR, aVL, aVF were recorded with surface electrodes (ADInstruments, Colorado Springs, CO). Measurements were collected at baseline, prior to training and after 7 weeks of exercise training. The mean value for each rat was obtained from four values consisting of four consecutive cardiac cycles using LabChart software (ADInstruments, Colorado Springs, CO). Corrected QT (QTC) was calculated with mean values and the Bazett's Formula (QTc = QT Interval/√ (RR interval) [18]. The heart rate (bpm) for each animal was calculated by dividing 60 by the mean RR interval. Heart rate variability (HRV) was measured as the standard deviation of the RR intervals.

Statistical analysis

Descriptive statistics was performed on animals' means for each group. One way repeated measures ANOVA (group) analyzed within and between subject differences and interactions. Single time point measurements or change scores were completed with one way ANOVA (group) with Least Significant Difference (LSD) post-hoc analysis. Pearson correlations were utilized for relationship values. Partial eta squared values are reported for the proportion of total variability attributed to a factor. Statistics were conducted with PASW Version 17 software (SPSS Inc, Chicago, IL, USA). Significance was measured at p < 0.05. Results are presented as means ± standard errors. The effect size of baseline body weights was large with Cohen's d = 2.8 and power was greater than 90% with sample sizes of 10-12 per group.

Results

Animal characteristics

A summary of animal characteristics are reported in Table 1 and weekly body weights are plotted in Figure 1. A significant difference in body weight between diabetic and control animals was observed at baseline and termination time points, F(3,40) = 19.37; p < 0.001. The mean difference between baseline and termination body weights indicated that control animals gained approximately 14% of their baseline body weights compared to a 5% gain for diabetic animals, p < 0.001. Diabetic animals outweighed their control counterparts by 9-12% at termination even with the discrepancy in weight gain. Although ED rats weighed less than SD animals at the termination, the ED rats were significantly heavier than SC and EC animals, p = 0.016 and p < 0.001 respectively. However, aging accounted for 64% of the variance in body weights as evident by average weight gains of 16-57 grams in all animal groups, F(1,39) = 71.29; p < 0.001. A moderate relationship between body weight and blood glucose levels existed at the baseline r(44) = 0.56; p < 0.001 and termination r(44) = 0.41; p < 0.01. The main effect of the group on blood glucose levels was modified by aging, F(1,39) = 3.02; p < 0.04. Although all animals had an increase in blood glucose levels, ED animals had only a 10% change compared to the 21% change of SD rats. HbA1C levels were elevated in diabetic groups compared to control groups, F(3,40) = 99.27; p < 0.001. Exercise did not attenuate HbA1C levels in ED animals, p = 0.92. Hyperglycemia is a factor in left ventricular hypertrophy development and progression but a correlation between A1C levels and heart weight/body weight ratios was not observed, r(44) = -0.17 p = 0.27. Heart weight/body weight ratios were similar for the animal groups, F(3,40) = 1.39; p = 0.26.
Table 1

Animal characteristics at baseline and termination

 

Sedentary Control

(SC) n = 10

Sedentary Diabetic

(SD) n = 12

Exercised Control

(EC) n = 12

Exercised Diabetic

(ED) n = 10

 

Baseline

Term

Baseline

Term

Baseline

Term

Baseline

Term

Body weight (g)

326 ± 13

381 ± 13

409 ± 34a, b, f

457 ± 41a, b, f

309 ± 30c, f

366 ± 22c, f

374 ± 24b, c, e

390 ± 23b, c

Blood glucose (mmol/L)

115 ± 9

145 ± 9

433 ± 144a, f

579 ± 35a, f

111 ± 11c, f

156 ± 12c, f

491 ± 136c

584 ± 22c, e

HbA1c (%)

ND

4.2 ± 0.3

ND

13.0 ± 0.0a, f

ND

4.7 ± 0.3c, d, f

ND

13.0 ± 0.0c, e

Heart rate (bpm)

355 ± 148

416 ± 190

393 ± 68

423 ± 84

358 ± 139

408 ± 100

397 ± 73

413 ± 81

Heart weight (g)

1.24 ± 0.12

1.29 ± 0.09f

1.15 ± 0.08d, f

1.22 ± 0.10

Heart weight/Body weight (mg/g)

3.27 ± 0.04

3.02 ± 0.03

3.16 ± 0.02

3.09 ± 0.03

Data are means ± SEs for each group with n as indicated. Statistical significance: Between group differences at baseline or termination (term) of p ≤ 0.05; ND - not determined; aSC vs SD, bSD vs ED, cEC vs ED, dSC vs EC, eSC vs ED and fSD vs EC.

Figure 1

Weekly mean body weight measurements. Data are means ± SEs for each group with n = 12 for sedentary diabetic (SD) and exercised control (EC); and n = 10 for sedentary control (SC) and exercise diabetic (ED) rats.

ECG wave amplitudes

R wave amplitude

R wave amplitudes were similar for groups at baseline except for the SD groups, F(3,40) = 15.16, p < 0.001. Therefore, statistical analyses used the change value for R wave amplitude to account for the difference at baseline. Gains in R wave amplitudes from baseline to termination of the experiment were only observed in the SD animals as reported in Figure 2. The SD rats had a 17% increase in R wave amplitude, suggesting left ventricular hypertrophy. A reduction in R wave amplitude was found in ED animals at termination. ED rats had change values similar to SC and EC animals, F(3,40) = 4.13, p = 0.84 and p = 0.87.
Figure 2

Mean R wave amplitude changes. Data are means ± SEs for each group with n = 12 for sedentary diabetic (SD) and exercised control (EC); and n = 10 for sedentary control (SC) and exercise diabetic (ED) rats. Statistical significance with p ≤ 0.05; aSC vs SD, bSD vs ED and fSD vs EC.

T wave amplitude

Due to the significant differences between diabetic groups at baseline, we analyzed the change of T wave amplitudes from baseline to termination (Figure 3). T wave amplitudes changes were similar in the four groups, F(3,40) = 1.81, p = 0.16.
Figure 3

Mean T wave amplitudes. Data are means ± SEs for each group with n = 12 for sedentary diabetic (SD) and exercised control (EC); and n = 10 for sedentary control (SC) and exercise diabetic (ED) rats. Statistical significance with p ≤ 0.05; bSD vs ED.

P wave amplitude

P wave amplitudes were similar between control and diabetic animals at baseline and termination, F(3,40) = 0.40, p = 0.99 (Figure 4). The amplitudes were decreased between baseline and termination in all four animal groups, as evident by time modifying the group effect, F(1,40) = 25.05, p < 0.001.
Figure 4

Mean P wave amplitudes. Data are means ± SEs for each group with n = 12 for sedentary diabetic (SD) and exercised control (EC); and n = 10 for sedentary control (SC) and exercise diabetic (ED) rats. Statistical significance (p < 0.001) between baseline and termination values was found in all four animal groups.

ECG intervals

RR intervals

A significant shortening of RR intervals and increased heart rates was observed in SD group at baseline when compared to the SC group, F(1,38) = 8.83, p < 0.01 (Table 2). At termination, only a trend toward tachycardia was observed SD animals compared to SC animals, F(3,36) = 2.79, p = 0.06. Exercise did not reverse the heart rate pattern for diabetic animals, p = 0.92. Table 2 shows that all animal groups had various levels of RR interval shortening at termination, but statistically an aging effect was not observed, F(1,38) = 0.34, p = 0.56. Decreased HRV was observed in all diabetic animals, sedentary and exercised compared to control animals F(1,38) = 1662.23, p < 0.01. HRV was not improved with exercise, p = 0.91 as calculated with the termination RR intervals of the ED animals.
Table 2

ECG interval measurements

 

Sedentary Control

(SC) n = 10

Sedentary Diabetic

(SD) n = 12

Exercised Control

(EC) n = 12

Exercised Diabetic

(ED) n = 10

 

Baseline

Term

Baseline

Term

Baseline

Term

Baseline

Term

RR interval (sec)

0.195 ± 0.077

0.152 ± 0.041

0.158 ± 0.033

0.132 ± 0.012

0.191 ± 0.073

0.158 ± 0.048

0.157 ± 0.036

0.135 ± 0.012

QRS interval (sec)

0.016 ± 0.005

0.022 ± 0.002

0.020 ± 0.002a, f

0.022 ± 0.004

0.016 ± 0.004c, f

0.023 ± 0.003

0.020 ± 0.002c, e

0.021 ± 0.004

QT interval (sec)

0.043 ± 0.012

0.040 ± 0.005

0.064 ± 0.013a, f

0.051 ± 0.012a, f

0.045 ± 0.012c, f

0.041 ± 0.006c, f

0.062 ± 0.011c, e

0.052 ± 0.013c, e

QT c interval (sec)

0.105 ± 0.043

0.105 ± 0.020

0.163 ± 0.033a, f

0.134 ± 0.034a, f

0.111 ± 0.043c, f

0.106 ± 0.018c, f

0.159 ± 0.026c, e

0.134 ± 0.037c, e

PR interval (sec)

0.032 ± 0.010

0.030 ± 0.006

0.045 ± 0.011a, f

0.034 ± 0.008

0.036 ± 0.012c, f

0.030 ± 0.005

0.046 ± 0.011c, e

0.034 ± 0.009

Data are means ± SEs for each group with n as indicated. Statistical significance: Between group differences at baseline or termination (term) of p ≤ 0.05; aSC vs SD, cEC vs ED, eSC vs ED and fSD vs EC.

QRS intervals

Widening of QRS intervals, a sign of abnormal intraventricular conduction, was found at baseline in diabetic animals, F(3,40) = 3.72, p < 0.01 (Table 2). An 18% difference existed in the duration of QRS intervals between the SC and SD animals. At termination, QRS intervals increased 6-9% for SD animals in comparison to 27-29% increases in SC animals. These changes implied that aging interacted with the main effect of the group, F(1,41) = 16.78, p < 0.001 and accounted for 29% of the variability of QRS intervals at termination. Therefore, the difference between SC and SD animals at baseline was lost at termination, F(3,40) = 0.57, p = 0.64. An impact of exercise on QRS intervals was not observed in the EC and ED animals.

QT and QTc intervals

SD animals presented with QT intervals (a measure of ventricular repolarization) 31% wider than SC animals at baseline, F(3,40) = 9.37, p < 0.001 (Table 2). After 7 weeks of exercise, QT intervals in ED animals remained widened, F(3,40) = 14.13, p = 0.85. At termination, the difference between SC and SD animals decreased to 21%. Aging accounted for 20% of the variability in termination QT intervals, but the group effect of diabetes accounted for 51% of the variability. An interaction between aging and group factors was not significant, and QT intervals were not affected by exercise in control or diabetic animals, p = 0.91 and p = 0.61.

QTc intervals (QT intervals corrected with RR intervals) were analyzed for an evaluation independent of heart rate. SD animals displayed significant widening of QTc intervals compared to SC animals, F(1,42) = 10.58, p < 0.001 (Table 2). Exercise did not attenuate the widening of QTc intervals in ED animals, p = 0.66. Compared to QT intervals, aging accounted for 85% of the variability in QTc intervals and 43% was due to group effects at termination. The interaction between time and group was significant, F(3,40) = 4.54, p < 0.01.

PR intervals

Baseline measurements revealed significant prolongation of PR intervals in SD animals compared to SC animals, F(1,39) = 5.40, p < 0.01 (Table 2). At termination, the difference between groups was not observed, p = 0.34. Exercise did not impact PR intervals in EC and ED animals.

Discussion

CVD risk is increased up to four-fold in people with diabetes compared with their nondiabetic counterparts [19]. Researchers are aggressively trying to identify early detection methods and explore the factors contributing to diabetes related heart disease. The ZDF rat model is routinely used to investigate physiological and molecular hypotheses regarding diabetes and its related complications. Reports are available indicating cardiac dysfunction in the ZDF rat established primarily with hemodynamic or echocardiographic measurements or through experiments on the isolated heart [2023]. However, limited information exists about the ECG changes that occur in the ZDF rat and its response to physical activity, specifically to aerobic exercise that is commonly recommended for those at risk or diagnosed with diabetes related heart disease [24, 25]. Our project aimed to address this gap in the current literature.

Although we did not measure autonomic function directly, ECG indicators of autonomic dysfunction were observed in the ZDF rats at baseline with HRV alterations, tachycardia and QT interval prolongation. Autonomic innervations control HRV and cardiac function through a delicate balance of sympathetic and parasympathetic responses. Diabetes stimulates the sympathetic nervous system initially but prolonged exposure to hyperglycemia and elevated catecholamine levels cause a decrease in adrenergic receptors [26]. As diabetes creates a sympathetic predominance, it also produces a corresponding parasympathetic imbalance by denervation of the vagus nerve. Subclinical symptoms of DAN, primarily decreased HRV, are believed to appear in humans within one year of type 2 diabetes diagnosis and clinical presentations may not emerge until years into the diagnosis [27]. Bergstrom et al identified symptoms of DAN in type 1 diabetic patients with durations of diabetes as low as two months [28]. In our animal study, diminished HRV was noted in ECG recordings as early as within one week of diabetes onset for the ZDF.

Clinical DAN symptoms include resting tachycardia, exercise intolerance and orthostatic hypotension and heart rate syndromes [29]. Tachycardia was observed in diabetic animals at baseline, within a week of diabetes onset. Tachycardia is also a common finding in humans with uncontrolled diabetes [30]. Similarly, our animals were not treated for their hyperglycemia as evident by blood glucose and HbA1C levels. The role of tachycardia is controversial because research indicates that it may be a diabetic complication or a causative factor of diabetes. Nagaya et al argue that elevated resting heart rates and systolic blood pressure increase the risk for type 2 diabetes [31]. Another work by the same group indicated that prolonged QTc intervals were also an independent risk factor for the development of diabetes [32]. Our analysis indicates that widening of QTc intervals was present with the onset of diabetes at twelve weeks of age in ZDF rats. Thus abnormalities of ventricular repolarization are present at an early stage of diabetes in this model. An earlier time study would be useful to verify the presence of tachycardia and QTc interval prolongation during a pre-diabetic state. Of interest, several ECG parameters in our study showed an impact of aging, in agreement with findings by others [33] indicating cardiac and renal changes in the ZDF rat model with aging, up to 36 months.

P wave amplitudes were unaffected with the onset of diabetes. Future studies need to investigate the relationship between the dispersion of the P wave and the onset of diabetes. Obesity is commonly linked to diabetes and is reported to increase the dispersion of the P wave [34]. PR intervals were widened in diabetic animals at baseline, but normalized at termination. PR intervals are commonly associated with atrial fibrillation [35, 36]; however our ECG assessments of diabetic animals did not indicate atrial dysfunction. Diabetes and exercise appeared to have no effect on T wave amplitudes. T wave amplitudes were skewed at baseline and therefore change scores were used for analysis. However, the morphology of the T wave has shown to have prognostic value for CVD, not amplitude changes [37, 38].

After seven weeks of aerobic exercise, ED animals showed R wave amplitudes comparable to control animals. Only SD animals had an increase in R wave amplitude. Hyperglycemia is associated with left ventricular hypertrophy in type 2 diabetes [39]. The increase in R wave amplitude may indicate a change in left ventricular mass. With diabetes, pathological hypertrophy results from myocardial damage and fibrosis [4042]. Fibrosis affects the filling and contractility of the ventricles. Subsequently, cardiac dysfunction presents as decreased activity tolerance, ejection fraction, cardiac output and heart failure [43]. However, other factors can alter R wave amplitudes, including electrical axis deviations, altered electrodes position and differences in chest wall thickness. Ideally, the ECG should be correlated with an echocardiography. Unfortunately, we were unable to use echocardiography approach, thus we recognize this as a limitation of this study. In analyzing other indications of heart hypertrophy, we found no difference in the heart weight/body weight ratio in our study. Alternatively, the LV weight/tibial length ratio has been validated as an index of cardiac hypertrophy in mature rats [44]. Due to the fact that the onset of diabetes in the ZDF rat occurs early in their age, we were restricted to using relatively young animals that were in the latter stages of their growth phase. Thus, normalizing heart size to the changing tibial bone length during growth may not have provided an accurate estimation in our study. Darmellah et al reported that normalization of the heart weight per body weight or tibial length resulted in similar measurements of cardiac hypertrophy in Goto-Kakizaki animals, another rat model of type 2 diabetes [45].

Aerobic exercise did not impact the hyperglycemia. Exercise is postulated to improve glucose uptake and decrease lipid accumulation in persons with controlled diabetes but the protective mechanism of exercise is lost if hyperglycemia persist [46]. A comparative study of fenobirate and metformin validated the role of lipid oxidation in the development and progression of diabetes related heart disease, with fenobirate decreasing triglycerides content and fibrosis in diabetic myocardium [47]. The switch in myocardial substrate from glucose to fatty acids has been shown to result in systolic and diastolic dysfunction in the ZDF model [48]. Exercise training has also been suggested to improve microcirculation through enhanced endothelial function [49] through normalizing glycemic levels. However, the severity of diabetes will determine if the body can adapt to the demands of exercise or regional flow has already been compromised beyond recovery [50]. Microcirculatory disturbances or small vessel disease may lead to declines in myocardial blood flow which could influence ECG parameters [51].

A 31% difference in QT intervals was reported between SC and SD animals at baseline. We hypothesize that cardiac remodeling was already in the process in the SD rats when we were taking the baseline measures, prior to any training, due to animals already displaying hyperglycemia and obesity associated with the genotype, in contrast to the SC rat. QTc intervals did not respond to exercise, but the chronic tachycardia shortened the intervals as a compensatory effect. Commonly, exercise may cause a decrease in heart rate and increased ventricular relaxation which presents as longer QT intervals. A study investigating the effects of a seven month endurance training program in dogs revealed an increase in QT intervals [52]. An acute resistance exercise resulted in a similar effect on QTc intervals [53]. Since our obese, diabetic animals were showing early signs of autonomic disturbance, exercise tolerance was lowered and animals required frequent rest breaks during our training program. The mode and duration of exercise might not have been sufficient for QTc interval adaptation. In a future study we will investigate longer durations of exercise training to see whether it may return diabetic animals to normal heart rates or restore HRV. Pagkalos et al reported improvements in cardiac autonomic function with six months of aerobic exercise training [54]. Another alternative is the evaluation of HRV during post-exercise recovery. Training may not affect resting HRV, but the benefits may be evident with the post-exercise recovery. This conclusion is supported by a study investigating cardiac autonomic function in women with and without diabetes [55].

Conclusions

In summary, our investigation proved that ECG alterations do occur with diabetes in the ZDF rat. The alterations include prolongation of the QTc interval and tachycardia which constitute important electrophysiologic alterations in this animal model of diabetes. These modifications coupled with high R wave amplitude illustrate the early cardiac anatomic and electrophysiologic alterations in this diabetic model. After seven weeks of exercise training, R wave amplitude changes in diabetes were similar to control animals from baseline to termination. However, aging may have an impact on several ECG parameters and the ZDF model showed changes in atrial and ventricular conduction possibly due to an interaction of aging and group effects. Future studies are needed to investigate ECG changes in the ZDF model before the onset of diabetes which will provide additional information about the use of QTc intervals and HRV in the early detection of DAN.

Declarations

Acknowledgements

We thank Aziz Shaibekov and Purvi Patel for helping with animal exercise training.

National Institutes of Health Grant Number P20 RR016475 from the INBRE Program of the National Center for Research Resources (IVS) provided resources for conducting the study. The U.S. Department of Health and Human Service through a National Research Service Award from the National Heart, Lung, and Blood Institute (LVH) supported analysis and interpretation of data and manuscript development. National Institute of Child Health and Human Development Grant Number HD02528 supported core facility services.

Authors’ Affiliations

(1)
Department of Physical Therapy and Rehabilitation Science, University of Kansas Medical Center
(2)
Mid America Cardiology, University of Kansas Hospital
(3)
Department of Allied Medical Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology

References

  1. Gorodeski EZ, Ishwaran H, Blackstone EH, Lauer MS: Quantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms. Am Heart J. 2009, 158 (1): 61-70. 10.1016/j.ahj.2009.04.015.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Cardoso CR, Salles GF, Deccache W: QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus. Stroke. 2003, 34 (9): 2187-2194. 10.1161/01.STR.0000085084.15144.66.View ArticlePubMedGoogle Scholar
  3. Christensen PK, Gall MA, Major-Pedersen A, Sato A, Rossing P, Breum L, Pietersen A, Kastrup J, Parving HH: QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest. 2000, 60 (4): 323-332. 10.1080/003655100750046486.View ArticlePubMedGoogle Scholar
  4. Mathur C, Gupta D: QTc prolongation in diabetes mellitus-An indicator of cardiac autonomic neuropathy. Journal, Indian Academy Clinical Medicine. 2006, 7 (2): 130-132.Google Scholar
  5. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, Heiss G: Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2005, 28 (3): 668-674. 10.2337/diacare.28.3.668.View ArticlePubMedGoogle Scholar
  6. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Wachtell K, Papademetriou V, Jern S, Dahlof B, Devereux RB, Okin PM: Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. J Hypertens. 2001, 19 (10): 1883-1891. 10.1097/00004872-200110000-00025.View ArticlePubMedGoogle Scholar
  7. Davey PP, Barlow C, Hart G: Prolongation of the QT interval in heart failure occurs at low but not at high heart rates. Clin Sci (Lond). 2000, 98 (5): 603-610. 10.1042/CS19990261.View ArticleGoogle Scholar
  8. Pshenichnikov I, Shipilova T, Kaik J, Volozh O, Abina J, Lass J, Karai D: QT dispersion in relation to left ventricular geometry and hypertension in a population study. Scand Cardiovasc J. 2003, 37 (2): 87-90.PubMedGoogle Scholar
  9. Nakamura K, Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Ueshima H: Electrocardiogram screening for left high R-wave predicts cardiovascular death in a Japanese community-based population: NIPPON DATA90. Hypertens Res. 2006, 29 (5): 353-360. 10.1291/hypres.29.353.View ArticlePubMedGoogle Scholar
  10. Zhang X, Wang X, Li L, Zhang G, Gao Y, Cui J: An analysis of factors influencing electrocardiogram stress test for detecting coronary heart disease. Chin Med J (Engl). 1999, 112 (7): 590-592.Google Scholar
  11. Perhonen MA, Haapalahti P, Kivisto S, Hekkala AM, Vaananen H, Swan H, Toivonen L: Effect of physical training on ventricular repolarization in type 1 long QT syndrome: a pilot study in asymptomatic carriers of the G589 D KCNQ1 mutation. Europace. 2006, 8 (10): 894-898. 10.1093/europace/eul083.View ArticlePubMedGoogle Scholar
  12. Genovesi S, Zaccaria D, Rossi E, Valsecchi MG, Stella A, Stramba-Badiale M: Effects of exercise training on heart rate and QT interval in healthy young individuals: are there gender differences?. Europace. 2007, 9 (1): 55-60. 10.1093/europace/eul145.View ArticlePubMedGoogle Scholar
  13. Tuomainen P, Peuhkurinen K, Kettunen R, Rauramaa R: Regular physical exercise, heart rate variability and turbulence in a 6-year randomized controlled trial in middle-aged men: the DNASCO study. Life Sci. 2005, 77 (21): 2723-2734. 10.1016/j.lfs.2005.05.023.View ArticlePubMedGoogle Scholar
  14. Sandercock GR, Bromley PD, Brodie DA: Effects of exercise on heart rate variability: inferences from meta-analysis. Med Sci Sports Exerc. 2005, 37 (3): 433-439. 10.1249/01.MSS.0000155388.39002.9D.View ArticlePubMedGoogle Scholar
  15. Schmidt RE, Dorsey DA, Beaudet LN, Peterson RG: Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy. Am J Pathol. 2003, 163 (1): 21-28.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ: Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol. 2005, 42 (4): 162-170. 10.1007/s00592-005-0197-8.View ArticlePubMedGoogle Scholar
  17. Searls YM, Smirnova IV, Fegley BR, Stehno-Bittel L: Exercise attenuates diabetes-induced ultrastructural changes in rat cardiac tissue. Med Sci Sports Exerc. 2004, 36 (11): 1863-1870. 10.1249/01.MSS.0000145461.38224.EC.View ArticlePubMedGoogle Scholar
  18. Heffernan KS, Jae SY, Fernhall B: Heart rate recovery after exercise is associated with resting QTc interval in young men. Clin Auton Res. 2007, 17 (6): 356-363. 10.1007/s10286-007-0450-z.View ArticlePubMedGoogle Scholar
  19. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB, Savage PJ, Levy D, Fox CS: Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 2009, 119 (13): 1728-1735. 10.1161/CIRCULATIONAHA.108.829176.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Boudina S, Abel ED: Diabetic cardiomyopathy revisited. Circulation. 2007, 115 (25): 3213-3223. 10.1161/CIRCULATIONAHA.106.679597.View ArticlePubMedGoogle Scholar
  21. Baynes JW, Murray DB: The metal chelators, trientine and citrate, inhibit the development of cardiac pathology in the Zucker diabetic rat. Exp Diabetes Res. 2009, 2009: 696378.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Radovits T, Korkmaz S, Loganathan S, Barnucz E, Bomicke T, Arif R, Karck M, Szabo G: Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2009, 297 (1): H125-133. 10.1152/ajpheart.00165.2009.View ArticlePubMedGoogle Scholar
  23. van den Brom CE, Bosmans JW, Vlasblom R, Handoko LM, Huisman MC, Lubberink M, Molthoff CF, Lammertsma AA, Ouwens MD, Diamant M, et al: Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle. Cardiovasc Diabetol. 2010, 9: 25-10.1186/1475-2840-9-25.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Mizuno R, Fujimoto S, Saito Y, Nakamura S: Exercise-induced delayed onset of left ventricular early relaxation in association with coronary microcirculatory dysfunction in patients with diabetes mellitus. J Card Fail. 2010, 16 (3): 211-217. 10.1016/j.cardfail.2009.10.024.View ArticlePubMedGoogle Scholar
  25. Chipkin SR, Klugh SA, Chasan-Taber L: Exercise and diabetes. Cardiol Clin. 2001, 19 (3): 489-505. 10.1016/S0733-8651(05)70231-9.View ArticlePubMedGoogle Scholar
  26. Scott LA, Kench PL: Cardiac autonomic neuropathy in the diabetic patient: does 123I-MIBG imaging have a role to play in early diagnosis?. J Nucl Med Technol. 2004, 32 (2): 66-71.PubMedGoogle Scholar
  27. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care. 2003, 26 (5): 1553-1579. 10.2337/diacare.26.5.1553.View ArticlePubMedGoogle Scholar
  28. Bergstrom B, Lilja B, Osterlin S, Sundkvist : Autonomic neuropathy in type 1 diabetes: influence of diabetes and other complications. Acta Med Scand. 2009, 222 (2): 147-154. 10.1111/j.0954-6820.1987.tb10652.x.View ArticleGoogle Scholar
  29. Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation. 2007, 115 (3): 387-397. 10.1161/CIRCULATIONAHA.106.634949.View ArticlePubMedGoogle Scholar
  30. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA: Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006, 29 (12): 2739-2748. 10.2337/dc06-9916.View ArticlePubMedGoogle Scholar
  31. Nagaya T, Yoshida H, Takahashi H, Kawai M: Resting heart rate and blood pressure, independent of each other, proportionally raise the risk for type-2 diabetes mellitus. Int J Epidemiol. 2010, 39 (1): 215-222. 10.1093/ije/dyp229.View ArticlePubMedGoogle Scholar
  32. Nagaya T, Yoshida H, Takahashi H, Kawai M: Heart rate-corrected QT interval in resting ECG predicts the risk for development of type-2 diabetes mellitus. Eur J Epidemiol. 2010, 25 (3): 195-202. 10.1007/s10654-009-9423-y.View ArticlePubMedGoogle Scholar
  33. Baynes J, Murray DB: Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats. Oxid Med Cell Longev. 2009, 2 (5): 328-334. 10.4161/oxim.2.5.9831.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Seyfeli E, Duru M, Kuvandik G, Kaya H, Yalcin F: Effect of obesity on P-wave dispersion and QT dispersion in women. Int J Obes (Lond). 2006, 30 (6): 957-961. 10.1038/sj.ijo.0803233.View ArticleGoogle Scholar
  35. Homoud MK: ACP Journal Club: Prolonged PR intervals were associated with increased risk for atrial fibrillation, pacemaker implantation, and mortality. Ann Intern Med. 2009, 151 (10): JC5-13. [http://www.annals.org/content/151/10/JC5-13.long]View ArticlePubMedGoogle Scholar
  36. Lorsheyd A, de Lange DW, Hijmering ML, Cramer MJ, van de Wiel A: PR and OTc interval prolongation on the electrocardiogram after binge drinking in healthy individuals. Neth J Med. 2005, 63 (2): 59-63.PubMedGoogle Scholar
  37. Nair D, Tan SY, Gan HW, Lim SF, Tan J, Zhu M, Gao H, Chua NH, Peh WL, Mak KH: The use of ambulatory tonometric radial arterial wave capture to measure ambulatory blood pressure: the validation of a novel wrist-bound device in adults. J Hum Hypertens. 2008, 22 (3): 220-222. 10.1038/sj.jhh.1002306.View ArticlePubMedGoogle Scholar
  38. Huang HC, Lin LY, Yu HY, Ho YL: Risk stratification by T-wave morphology for cardiovascular mortality in patients with systolic heart failure. Europace. 2009, 11 (11): 1522-1528. 10.1093/europace/eup294.View ArticlePubMedGoogle Scholar
  39. Goraksha-Hicks P, Rathmell JC: TGF-beta: a new role for an old AktTOR. Dev Cell. 2009, 17 (1): 6-8. 10.1016/j.devcel.2009.07.004.PubMed CentralView ArticlePubMedGoogle Scholar
  40. Fukui S, Fukumoto Y, Suzuki J, Saji K, Nawata J, Shinozaki T, Kagaya Y, Watanabe J, Shimokawa H: Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin-angiotensin system in hypertensive rats. Hypertens Res. 2009, 32 (6): 472-480. 10.1038/hr.2009.43.View ArticlePubMedGoogle Scholar
  41. Kannel WB: Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1983, 75 (3A): 4-11. 10.1016/0002-9343(83)90111-0.View ArticlePubMedGoogle Scholar
  42. Seferovic PM, Lalic NM, Seferovic JP, Jotic A, Lalic K, Ristic AD, Simeunovic D, Radovanovic G, Vujisic-Tesic B, Ostajic MU: [Diabetic cardiomyopathy: old disease or new entity?]. Srp Arh Celok Lek. 2007, 135 (9-10): 576-582.PubMedGoogle Scholar
  43. Kannel WB, Levy D, Cupples LA: Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. J Cardiovasc Pharmacol. 1987, 10 (Suppl 6): S135-140.View ArticlePubMedGoogle Scholar
  44. Yin FC, Spurgeon HA, Rakusan K, Weisfeldt ML, Lakatta EG: Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol. 1982, 243 (6): H941-947.PubMedGoogle Scholar
  45. Darmellah A, Baetz D, Prunier F, Tamareille S, Rucker-Martin C, Feuvray D: Enhanced activity of the myocardial Na+/H+ exchanger contributes to left ventricular hypertrophy in the Goto-Kakizaki rat model of type 2 diabetes: critical role of Akt. Diabetologia. 2007, 50 (6): 1335-1344. 10.1007/s00125-007-0628-x.View ArticlePubMedGoogle Scholar
  46. Sato Y: Diabetes and life-styles: role of physical exercise for primary prevention. Br J Nutr. 2000, 84 (Suppl 2): S187-190.View ArticlePubMedGoogle Scholar
  47. Forcheron F, Basset A, Abdallah P, Del Carmine P, Gadot N, Beylot M: Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model--the Zucker diabetic rat. Cardiovasc Diabetol. 2009, 8: 16-10.1186/1475-2840-8-16.PubMed CentralView ArticlePubMedGoogle Scholar
  48. van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, van der Velden J, Boer C, et al: Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol. 2009, 8: 39-10.1186/1475-2840-8-39.PubMed CentralView ArticlePubMedGoogle Scholar
  49. Erbs S, Hollriegel R, Linke A, Beck EB, Adams V, Gielen S, Mobius-Winkler S, Sandri M, Krankel N, Hambrecht R, et al: Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function. Circ Heart Fail. 2010, 3 (4): 486-494. 10.1161/CIRCHEARTFAILURE.109.868992.View ArticlePubMedGoogle Scholar
  50. Joshi D, Shiwalkar A, Cross MR, Sharma SK, Vachhani A, Dutt C: Continuous, non-invasive measurement of the haemodynamic response to submaximal exercise in patients with diabetes mellitus: evidence of impaired cardiac reserve and peripheral vascular response. Heart. 2010, 96 (1): 36-41. 10.1136/hrt.2009.177113.PubMed CentralView ArticlePubMedGoogle Scholar
  51. Cosyns B, Droogmans S, Hernot S, Degaillier C, Garbar C, Weytjens C, Roosens B, Schoors D, Lahoutte T, Franken PR, et al: Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol. 2008, 7: 26-10.1186/1475-2840-7-26.PubMed CentralView ArticlePubMedGoogle Scholar
  52. Constable PD, Hinchcliff KW, Olson JL, Stepien RL: Effects of endurance training on standard and signal-averaged electrocardiograms of sled dogs. Am J Vet Res. 2000, 61 (5): 582-588. 10.2460/ajvr.2000.61.582.View ArticlePubMedGoogle Scholar
  53. Heffernan KS, Sosnoff JJ, Jae SY, Gates GJ, Fernhall B: Acute resistance exercise reduces heart rate complexity and increases QTc interval. Int J Sports Med. 2008, 29 (4): 289-293. 10.1055/s-2007-965363.View ArticlePubMedGoogle Scholar
  54. Pagkalos M, Koutlianos N, Kouidi E, Pagkalos E, Mandroukas K, Deligiannis A: Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy. Br J Sports Med. 2008, 42 (1): 47-54. 10.1136/bjsm.2007.035303.View ArticlePubMedGoogle Scholar
  55. Figueroa A, Baynard T, Fernhall B, Carhart R, Kanaley JA: Endurance training improves post-exercise cardiac autonomic modulation in obese women with and without type 2 diabetes. Eur J Appl Physiol. 2007, 100 (4): 437-444. 10.1007/s00421-007-0446-3.View ArticlePubMedGoogle Scholar

Copyright

© VanHoose et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement